HELPix Care Plan for Medical Complexity in Children
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether participants must stop taking their current medications.
What data supports the effectiveness of the HELPix Care Plan treatment for medical complexity in children?
The HELPix Care Plan treatment is supported by research showing that care coordination and structured care plans improve outcomes for children with medical complexity. These approaches help reduce hospital admissions and emergency room visits, improve communication among healthcare providers, and enhance the overall quality of care for children and their families.12345
Is the HELPix Care Plan safe for children with medical complexity?
How is the HELPix Care Plan treatment different from other treatments for children with medical complexity?
The HELPix Care Plan is unique because it focuses on creating a comprehensive care plan with clearly defined roles for care teams, improving communication, and setting specific goals to support children with medical complexity. This approach helps keep children in their local medical homes and reduces the need for hospital visits, unlike traditional treatments that may not offer such coordinated care.18101112
What is the purpose of this trial?
The overarching objective of this study is to make it easier for parents of children with medical complexity (CMC) to take care of their children after discharge home from the hospital and reduce the chance of post-hospitalization morbidity (meaning bad outcomes such as readmissions) after discharge. CMC, or those with multiple chronic conditions, progressive conditions, or technology dependence, are at high risk for post-hospitalization morbidity.
Research Team
Alexander F Glick, MD, MS
Principal Investigator
NYU Langone Health
Eligibility Criteria
This trial is for parents or legal guardians who are the primary caregivers of children with complex medical needs, such as chronic conditions in multiple body systems, reliance on technology like respiratory equipment, or serious progressive illnesses. The child must be under 18 years old and discharged home on medication. Caregivers must speak English or Spanish and be willing to participate fully in the study.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Aim 1: Interviews
Parents of CMC and pediatricians are interviewed to understand challenges and facilitators in following discharge instructions.
Aim 2: Tool Design
A tool is designed to help parents understand and follow discharge instructions, using findings from Aim 1 and extensive testing.
Aim 3: Randomized Controlled Trial
RCT to study the impact of the tool on parent comprehension and adherence to discharge instructions, and post-discharge morbidity.
Follow-up
Participants are monitored for post-discharge morbidity, including readmissions and emergency department visits.
Treatment Details
Interventions
- HELPix Care Plan
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator